Julia Lowin

560 total citations
26 papers, 401 citations indexed

About

Julia Lowin is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, Julia Lowin has authored 26 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 7 papers in Pediatrics, Perinatology and Child Health and 7 papers in Epidemiology. Recurrent topics in Julia Lowin's work include Reproductive Health and Contraception (6 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Global Maternal and Child Health (6 papers). Julia Lowin is often cited by papers focused on Reproductive Health and Contraception (6 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Global Maternal and Child Health (6 papers). Julia Lowin collaborates with scholars based in United Kingdom, United States and Germany. Julia Lowin's co-authors include Anna Filonenko, James Trussell, Fareen Hassan, Eifiona Wood, Annika Bergman, Leslie J. Findley, Amy Law, К. Ray Chaudhuri, Raj Patel and Dominic Muston and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal of Radiology and Value in Health.

In The Last Decade

Julia Lowin

26 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia Lowin United Kingdom 11 155 109 106 61 56 26 401
Eric Cheng United States 13 84 0.5× 93 0.9× 40 0.4× 59 1.0× 120 2.1× 25 556
Kristina Jurėnienė Lithuania 12 156 1.0× 31 0.3× 47 0.4× 17 0.3× 37 0.7× 25 439
Craig Lipkin United States 10 50 0.3× 20 0.2× 66 0.6× 12 0.2× 32 0.6× 33 401
Loyal Pattuwage Australia 13 95 0.6× 91 0.8× 11 0.1× 21 0.3× 94 1.7× 21 388
Gimena Hernández Spain 9 77 0.5× 20 0.2× 68 0.6× 72 1.2× 86 1.5× 12 458
Ambereen K. Mehta United States 12 348 2.2× 82 0.8× 71 0.7× 14 0.2× 84 1.5× 42 586
Khalid A Altirkawi Saudi Arabia 11 49 0.3× 20 0.2× 67 0.6× 10 0.2× 51 0.9× 17 406
Nivethika Jeyakumar Canada 13 36 0.2× 9 0.1× 35 0.3× 15 0.2× 36 0.6× 32 405
Milena N. Mareva United States 8 173 1.1× 19 0.2× 47 0.4× 53 0.9× 40 0.7× 8 472
Bang-An Luo China 10 116 0.7× 15 0.1× 69 0.7× 7 0.1× 38 0.7× 16 509

Countries citing papers authored by Julia Lowin

Since Specialization
Citations

This map shows the geographic impact of Julia Lowin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Lowin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Lowin more than expected).

Fields of papers citing papers by Julia Lowin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Lowin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Lowin. The network helps show where Julia Lowin may publish in the future.

Co-authorship network of co-authors of Julia Lowin

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Lowin. A scholar is included among the top collaborators of Julia Lowin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Lowin. Julia Lowin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lowin, Julia, et al.. (2024). Cost-consequence analysis of a combined COVID-19/influenza rapid diagnostic test in the Brazilian private healthcare setting. The Brazilian Journal of Infectious Diseases. 28(4). 103840–103840. 1 indexed citations
3.
Jones, Mari, et al.. (2023). The Economic Potential of Smoking Cessation Interventions at the Point of Diagnosis of Non–Small Cell Lung Cancer. Value in Health. 26(8). 1192–1200. 3 indexed citations
4.
Humphrey, Neil, Margarita Panayiotou, Kimberly Petersen, et al.. (2022). The Good Behaviour Game intervention to improve behavioural and other outcomes for children aged 7–8 years: a cluster RCT. SHILAP Revista de lepidopterología. 10(7). 1–100. 8 indexed citations
5.
Poudel, Ak Narayan, et al.. (2021). The cost of inpatient burn management in Nepal. Burns. 47(7). 1675–1682. 10 indexed citations
6.
Lowin, Julia, et al.. (2019). Estimating the cost impact of dressing choice in the context of a mass burns casualty event.. PubMed. 32(3). 222–226. 5 indexed citations
7.
Basson, Mickaël, et al.. (2017). The Cost-effectiveness of Dulaglutide 1.5mg versus Exenatide QW for the Treatment of Patients with Type 2 Diabetes Mellitus in France. Diabetes Therapy. 9(1). 13–25. 12 indexed citations
8.
Lin, Huan, et al.. (2016). The Cost-Effectiveness of Dulaglutide Versus Liraglutide in Patients with Type 2 Diabetes Mellitus in Taiwan. Value in Health. 19(7). A898–A898. 1 indexed citations
9.
10.
Lowin, Julia, et al.. (2015). Cost-Effectiveness of Dulaglutide 1.5mg Once Weekly for the Treatment of Patients with Type Two Diabetes Mellitus in Sweden. Value in Health. 18(7). A607–A607. 5 indexed citations
11.
Black, Amanda, Édith Guilbert, Fareen Hassan, et al.. (2015). The Cost of Unintended Pregnancies in Canada: Estimating Direct Cost, Role of Imperfect Adherence, and the Potential Impact of Increased Use of Long-Acting Reversible Contraceptives. Journal of Obstetrics and Gynaecology Canada. 37(12). 1086–1097. 41 indexed citations
12.
Trussell, James, Fareen Hassan, Julia Lowin, Amy Law, & Anna Filonenko. (2014). Achieving cost-neutrality with long-acting reversible contraceptive methods. Contraception. 91(1). 49–56. 54 indexed citations
13.
Lowin, Julia, et al.. (2014). Direct Costs of Unintended Pregnancy in the Russian Federation. Applied Health Economics and Health Policy. 13(1). 61–68. 3 indexed citations
14.
Fredrikson, S., Euan McLeod, Nathaniel Henry, et al.. (2013). A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden. Journal of Medical Economics. 16(6). 756–762. 5 indexed citations
15.
Trussell, James, Fareen Hassan, Julia Lowin, Amy Law, & Anna Filonenko. (2013). Annualized costs of contraceptive products in the united states: a comparison of long-acting and short-acting reversible methods. Contraception. 88(3). 453–453. 1 indexed citations
16.
Kourlaba, Georgia, Nikos Maniadakis, Athanasios Giannoukas, et al.. (2012). PCV54 Economic Evaluation of Rivaroxaban in the Treatment of Deep Vein Thrombosis in Greece. Value in Health. 15(7). A372–A372. 1 indexed citations
17.
Lowin, Julia, et al.. (2011). The Burden of Moderate/Severe Premenstrual Syndrome and Premenstrual Dysphoric Disorder in a Cohort of Latin American Women. Value in Health. 14(5). S93–S95. 31 indexed citations
18.
Findley, Leslie J., et al.. (2011). The economic burden of advanced Parkinson’s disease: an analysis of a UK patient dataset. Journal of Medical Economics. 14(1). 130–139. 57 indexed citations
19.
Lowin, Julia, Annika Bergman, К. Ray Chaudhuri, et al.. (2011). A cost-effectiveness analysis of levodopa/carbidopa intestinal gel compared to standard care in late stage Parkinson’s disease in the UK. Journal of Medical Economics. 14(5). 584–593. 40 indexed citations
20.
Ananthapavan, Jaithri, Julia Lowin, & Emma Frances Bloomfield. (2010). Economic report : home haemodialysis. Deakin Research Online (Deakin University). 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric Cheng Breakdown of academic impact, for papers by Kristina Jurėnienė Breakdown of academic impact, for papers by Craig Lipkin Breakdown of academic impact, for papers by Loyal Pattuwage Breakdown of academic impact, for papers by Gimena Hernández Breakdown of academic impact, for papers by Ambereen K. Mehta Breakdown of academic impact, for papers by Khalid A Altirkawi Breakdown of academic impact, for papers by Nivethika Jeyakumar Breakdown of academic impact, for papers by Milena N. Mareva Breakdown of academic impact, for papers by Bang-An Luo
Rankless by CCL
2026